Malignant Melanoma News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Role of ubenimex as an anticancer drug and its synergistic effect with Akt inhibitor in human A375 and A2058 cells - Dove Medical Press



Role of ubenimex as an anticancer drug and its synergistic effect with Akt inhibitor in human A375 and A2058 cells 
Dove Medical Press
Background: Malignant melanoma (MM) is a malignant tumor produced by changes in melanocytes in the skin or other organs. In the classification of skin tumor mortality, skin melanoma ranks the highest. Ubenimex, an Aminopeptidase N (APN) inhibitor, is ...

 


No definitive causal link between sunbed use and malignant melanoma - Science Daily



No definitive causal link between sunbed use and malignant melanoma 
Science Daily
Can artificial UV radiation cause malignant melanoma in humans? In light of the observed increase in skin cancer rates, this question is one that has been and continues to be addressed in numerous studies. An international team of researchers ...

 


Melanoma : Get Any Unusual Bumps Or Lumps Checked - HuffPost South Africa



HuffPost South Africa
 
Melanoma : Get Any Unusual Bumps Or Lumps Checked 
HuffPost South Africa
A doctor's visit to have the mole checked confirmed that she had stage three malignant melanoma ? the most serious form of skin cancer. 'There was something strange about how it looked.' "I had not even had symptoms," she said. What followed was ...

 


The 'Ugly Duckling' Rule in Melanoma Self-exam - Medscape



Medscape
 
The 'Ugly Duckling' Rule in Melanoma Self-exam 
Medscape
Since its development in 1985, the ABCD rule (A=asymmetry, B=border irregularity, C=color variegation, D=diameter larger than 6 mm) has been taught as a simple pattern recognition tool to distinguish normal melanocytic nevi from melanomas. This simple ...

 


Xcovery Announces Initiation of Phase 2 Clinical Trial for Ensartinib in Melanoma Patients with ALK Alternations - Business Wire (press release)



Business Wire (press release)
 
Xcovery Announces Initiation of Phase 2 Clinical Trial for Ensartinib in Melanoma Patients with ALK Alternations 
Business Wire (press release)
?While there has been significant clinical advancements in the treatment of advanced malignant melanoma, 30 to 40 percent of patients do not respond to immune-based therapy or will develop therapeutic resistance. This is a promising trial that uses an ...

 


The Vet's Office: Oral Observation - Hub City Times



Hub City Times
 
The Vet's Office: Oral Observation 
Hub City Times
If the tumor is malignant, it typically grows faster and has the potential to spread to other areas ? 90 percent of cat oral tumors are malignant, and the most common one is a carcinoma. It favors tissues under the tongue but can also occur on the gums ...

and more » 


Nanorobots Target And Attack Malignant Tumors Without Harming Healthy Tissue - Forbes



Forbes
 
Nanorobots Target And Attack Malignant Tumors Without Harming Healthy Tissue 
Forbes
An IV was used to inject the nanorobots into the bloodstream of mice with breast cancer, melanoma, ovarian or lung cancer tumors. Within hours the nanorobots had located and surrounded the tumors. Within 24 hours, tissue damage that resulted from ...
Researchers use nanorobots to kill tumors in mice Engadget
A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo | Nature Biotechnology Nature
Cancer-fighting nanorobots seek and destroy tumors Arizona State University
The Independent 
all 68 news articles » 


Immunotherapy Cancer Treatment : Patient Testimonial - Longevity LIVE



Longevity LIVE
 
Immunotherapy Cancer Treatment : Patient Testimonial 
Longevity LIVE
I had stage III malignant melanoma, the most serious form of skin cancer. I underwent treatment with a regimen that was available at the time for a year. The impact of the treatment on my life was substantial. I ran a large company and it was extremely ...

and more » 


Yervoy Approved in Europe to Treat Pediatric Patients with Advanced Melanoma - Immuno-Oncology News



Immuno-Oncology News
 
Yervoy Approved in Europe to Treat Pediatric Patients with Advanced Melanoma 
Immuno-Oncology News
The second study was a Phase 2 trial (NCT01696045) with 12 adolescents, ages 12 to 16, with unresectable stage 3 or 4 malignant melanoma. Participants received one of two Yervoy doses ? 3 mg/kg in four patients, and 10 mg/kg in eight patients ? every ...

 


Bowen's Disease Signs and Symptoms - News-Medical.net



News-Medical.net
 
Bowen's Disease Signs and Symptoms 
News-Medical.net
In these affected regions, the lesions accumulate as malignant melanoma. The pigmented lesions are seen particularly in the unexposed genital regions. Erythroplasia of Queryatis a lesion usually occurring on the glans of penis. In addition, reduced ...